Skip to content

Clinical trials

Cardiovascular Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: United States Clear all

1,708 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200113
200218
200335
200456
200535
200646
200749
200864
200969
201064
201161
201268
201359
201490
201572
201670
201767
201887
201968
202074
202177
202279
202392
202492
202574
202662

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,124
Recruiting213
Active, not recruiting106
Terminated102
Unknown status73
Withdrawn44
Not yet recruiting20
Enrolling by invitation17
Suspended7
No longer available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)62
VA Office of Research and Development44
Duke University36
Penn State University35
University of Pennsylvania34
Brigham and Women's Hospital30
Mayo Clinic27
Massachusetts General Hospital25
NYU Langone Health24
Emory University23

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases1,708
Heart Diseases244
Hypertension215
Diabetes Mellitus173
Obesity172
Vascular Diseases119
Atherosclerosis114
Heart Failure108
Diabetes Mellitus, Type 2104
Coronary Artery Disease97

Trials

Showing 1 to 25 of 1,708. Each trial links to its page on Pharma Observatory.

1,608 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.